A comparative analysis of the behaviour of urothelial carcinoma with respect to anatomical location

A comparative analysis of the behaviour of urothelial carcinoma with respect to anatomical location

Detalhes bibliográficos
Principais autores:	Catto, J, Yates, DR, Rehman, I, Patterson, J, Sibony, M, Cussenot, O, Hamdy, F
Formato:	Journal article
Publicado em:	2007

Registros relacionados

Behavior of urothelial carcinoma with respect to anatomical location.
por: Catto, J, et al.
Publicado em: (2007)

Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.
por: Catto, J, et al.
Publicado em: (2005)

The role of genetic instability in the pathogenesis and progression of urothelial carcinoma
por: Catto, J, et al.
Publicado em: (2005)

Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma.
por: Dhawan, D, et al.
Publicado em: (2006)

DNA promoter methylation in urothelial cancer: a feature of the invasive phenotype and a novel therapeutic target
por: Catto, J, et al.
Publicado em: (2006)

A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis.
por: Rouprêt, M, et al.
Publicado em: (2008)

Compared performance of microsatellite and methylation urinalysis in predicting recurrence in transitional cell carcinoma and definition of a diagnostic panel of markers by bayesian network analysis
por: Roupret, M, et al.
Publicado em: (2007)

[Mutation of the FGFR3 oncogene is an independent and favorable prognostic factor for tumor-specific survival in patients with urothelial carcinoma of the upper urinary tract].
por: Burger, M, et al.
Publicado em: (2006)

Mutation of the FGFR3 oncogene is an independent and favorable prognostic factor for tumor-specific survival in patients with urothelial carcinoma of the upper urinary tract
por: Burger, M, et al.
Publicado em: (2006)

Phenol sulfotransferase SULT1A1*2 allele and enhanced risk of upper urinary tract urothelial cell carcinoma.
por: Rouprêt, M, et al.
Publicado em: (2007)

Compared performance of microsatellite and methylation urinalysis in predicting recurrence in transitional cell carcinoma and definition of a diagnostic panel of markers by bayesian network analysis
por: Roupret, M, et al.
Publicado em: (2007)

Neurofuzzy modeling to determine recurrence risk following radical cystectomy for nonmetastatic urothelial carcinoma of the bladder.
por: Catto, J, et al.
Publicado em: (2009)

Epigenetic changes in urothelial cancer: A feature of the invasive phenotype and a novel therapeutic target
por: Catto, J, et al.
Publicado em: (2006)

A gene promoter hypermethylation panel to detect transitional cell carcinoma of the bladder
por: Yates, DR, et al.
Publicado em: (2006)

Distinct patterns of microsatellite instability are seen in tumours of the urinary tract.
por: Catto, J, et al.
Publicado em: (2003)

Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma.
por: Roupret, M, et al.
Publicado em: (2004)

Comparing gene promoter methylation frequencies in urine from patients with bladder cancer with urine from non-cancerous young and elderly control patients
por: Yates, DR, et al.
Publicado em: (2005)

Promoter hypermethylation in circulating blood cells identifies prostate cancer progression.
por: Rouprêt, M, et al.
Publicado em: (2008)

Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.
por: Rouprêt, M, et al.
Publicado em: (2005)

Promoter hypermethylation in circulating blood cells identifies prostate cancer progression
por: Roupret, M, et al.
Publicado em: (2008)

Reply from Authors re: David J. DeGraff. Novel Use of a Combined Artificial Intelligence Approach to Identify Patients with Noninvasive Urothelial Cell Carcinoma of the Urinary Bladder Who Are at Greatest Risk for Progression to Muscle-Invasive Disease: A Step Forward. Eur Urol 2010; 57: 407-8
por: Catto, J, et al.
Publicado em: (2010)

Urothelial Carcinoma
por: Nan-Haw Chow, et al.
Publicado em: (2012-01-01)

Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearance.
por: Catto, J, et al.
Publicado em: (2006)

Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls.
por: Yates, DR, et al.
Publicado em: (2006)

A brief review and case report of urothelial carcinoma and metachronous leiomyosarcoma of the bladder at the same anatomic region
por: Yajie Li, et al.
Publicado em: (2022-01-01)

Cytotoxic effect of cannabinoids on bladder urothelial carcinoma
por: J. Ramon, et al.
Publicado em: (2023-02-01)

Effects of tumor size and location on survival in upper tract urothelial carcinoma after nephroureterectomy
por: Shreyas S Joshi, et al.
Publicado em: (2018-01-01)

FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
por: van Oers, J, et al.
Publicado em: (2009)

Sarcomatoid urothelial carcinoma
por: Orelvys González Otaño, et al.
Publicado em: (2012-04-01)

Metastatic urothelial carcinoma
por: Elisabeth Gómez-Moyano, et al.
Publicado em: (2021-08-01)

S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors.
por: Rehman, I, et al.
Publicado em: (2004)

Clinically localised prostate cancer is microsatellite stable.
por: Azzouzi, A, et al.
Publicado em: (2007)

Editorial: Therapies and influences in urothelial carcinoma
por: G. Ozgun, et al.
Publicado em: (2022-12-01)

Update on the Treatment of Metastatic Urothelial Carcinoma
por: Nedal Bukhari, et al.
Publicado em: (2018-01-01)

Bladder melanosis with concurrent urothelial carcinoma
por: Susanna E. Yau, et al.
Publicado em: (2017-11-01)

Comparative gene expression profiling analysis of urothelial carcinoma of the renal pelvis and bladder
por: Teh Bin T, et al.
Publicado em: (2010-12-01)

Aberrant promoter methylation in pre-malignant and invasive tumours of the urinary bladder
por: Yates, D, et al.
Publicado em: (2005)

Genomics and Immunomics in the Treatment of Urothelial Carcinoma
por: Veronica Mollica, et al.
Publicado em: (2022-05-01)

Genetic instability and transitional cell carcinoma of the bladder.
por: Catto, J, et al.
Publicado em: (2004)

Nested Variant of Urothelial Carcinoma
por: Anthony Kodzo-Grey Venyo
Publicado em: (2014-01-01)